全球血管移植市场 – 行业趋势及 2028 年预测

市场分析与洞察：全球血管移植市场

血管移植市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率将达到 5.72%。患者对血管移植益处的认识不断提高，这将进一步为市场增长带来各种机会。

血管移植是外科手术治疗患病或受损血管的重要方法，通过更换血管来恢复血液流动。及时更换健康血管可确保延长寿命，并更好地控制患者的健康状况。

由于全球老年人口的不断增加，患心血管疾病、肾衰竭、血管疾病的患者数量激增，政府对预防性医疗保健的关注度不断提高，健康预期寿命的重要性不断提高，越来越多的人采用直接面向消费者的方式获取医疗保健服务，这些都是可能在 2021-2028 年预测期内促进血管移植市场增长的主要和重要因素。另一方面，研究活动数量的增加、筛查在精准和个性化药物中的应用不断增加，这些将进一步促进血管移植市场在上述预测期内的增长，从而创造巨大的机会。

不同公司提供的移植物价格波动，以及样品运输问题日益严重，这些都可能成为上述预计时间内血管移植物增长的市场制约因素。缺乏报销政策将成为市场增长的最大和最重要的挑战。

This vascular graft market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on vascular graft market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Vascular Graft Market Scope and Market Size

Vascular graft market is segmented on the basis of product type, material, application, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product type, vascular graft market is segmented into, haemodialysis grafts, coronary artery bypass grafts, peripheral vascular grafts, coronary stents, others.
• Based on material, vascular graft market is segmented into synthetic grafts, biosynthetic grafts, biological grafts, biosynthetic grafts. Synthetic grafts have been further segmented into Dacron, ePTFE, polyurethane and others. Biosynthetic grafts have been further segmented into ovine collage and others. Biological grafts have been further segmented into saphenous vein grafts, bovine vein grafts and others.
• On the basis of application, vascular graft market is segmented into coronary artery bypass, aneurysms, renal bypass, and chronic total occlusion.
• Based on end user, vascular graft market is segmented into hospitals, specialised clinics and ambulatory surgical centres.
• Vascular graft market has also been segmented based on the distribution channel into direct tenders, retail, others.

Vascular Graft Market Country Level Analysis

Vascular graft market is analysed and market size insights and trends are provided by country, product type, material, application, end user and distribution channel as referenced above.

The countries covered in the vascular graft market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The U.S. dominates the North America Vascular graft market due to the increasing occurrences of chronic diseases, rising focus on preventive healthcare, growing number of research and development activities, and prevalence of various local players in the region, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the rising initiatives of preventive healthcare in the region.

The country section of the vascular graft market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Vascular graft market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for vascular graft market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the vascular graft market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Vascular Graft Market Share Analysis

Vascular graft market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to vascular graft market.

血管移植市场报告中涉及的主要参与者包括 LeMaitre Vascular, Inc.、W.LGore & Associates Inc.、Medtronic PLC、B. Braun Melsungen AG.、JOTEC GmbH、Terumo Aortic. Laboratory Corporation of America Holdings.、Perouse Medical、CryoLife, Inc.、Affluent Medical、BD、Heart Medical、JunKun Medical Equipment Co., Inc. Getinge AB.、Cardinal Health. Boston Scientific Corporation、Abbott、ENDOLOGIX LL、Cardiatis SA.、Lombard Medical、NANO、BIOVIC Sdn Bhd. Biomedical Innovations 等。市场份额数据分别提供全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

SKU-27028